Eikon Therapeutics announced it will present seven abstracts at the 2026 European Society for Medical Oncology (ESMO) Congress, showcasing updates on its clinical pipeline. These include new data from trials of EIK1001 for stage 4 non-small cell lung cancer, EIK1003 for advanced solid tumors and metastatic prostate cancer, EIK1004 for advanced solid malignancies, and EIK1005 for advanced solid tumors. The presentations highlight progress in developing innovative cancer therapies using novel mechanisms like TLR7/8 dual agonists, PARP1 inhibitors, and WRN helicase inhibitors. This event marks a significant step in advancing Eikon's oncology programs and engaging with the broader medical community.
Eikon Therapeutics' presentations at the 2026 ESMO Congress provide context for health sector activity on Pluang. Of 150 priced Health-sector US stocks, 29 rose and 118 fell as of Oct 19, 2026 04:02 WIB. Notable movers include IBRX at USD 9.18 with a -8.20% change, TWST at USD 132.75 down 8.13%, and MRNA at USD 218.01 down 7.82%.
Disc Medicine announced a webcast on October 19, 2026, to discuss topline results from its APOLLO Phase 3 trial of bitopertin, an investigational oral drug for erythropoietic protoporphyria (EPP). Bitopertin targets glycine transporter 1 to modulate ...
Tech analyst James Altucher draws a parallel between the 1865 coal consumption surge and AI's increasing power needs, despite efficiency gains. He highlights Elon Musk's unique strategy of vertical integration, including plans to build AI data center...
BitTorrent has completed its inaugural burn of BTT tokens, using 100% of decentralized service revenue to repurchase and permanently remove over 21.6 trillion tokens from circulation. This marks a key step in BitTorrent's long-term strategy to create...
Bank of America is under investigation after the U.S. Treasury Department fined the bank approximately $1.21 billion for failing to comply with anti-money laundering regulations and U.S. sanctions. Regulators found the bank neglected to properly inve...
NEAR cryptocurrency price fell about 17% this week, currently trading near $4.895 after dropping to a low of $4.527. The $4.30 level has acted as a key support and pivot point throughout 2024, anchoring the bullish outlook. Analysts highlight that ho...
